CA
EXAS

Calton & Associates’s Exact Sciences EXAS Stock Holding History

Calton & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,588
Closed -$243K – 155
2023
Q2 		$243K Buy
+2,588
New +$202K 0.11% 168
2021
Q3 		– Sell
-1,880
Closed -$234K – 412
2021
Q2 		$234K Sell
1,880
-10
-0.5% -$1.19K 0.04% 351
2021
Q1 		$249K Sell
1,890
-1
-0.1% -$137 0.05% 325
2020
Q4 		$251K Sell
1,891
-684
-27% -$82.7K 0.04% 304
2020
Q3 		$263K Sell
2,575
-93
-3% -$8.03K 0.05% 255
2020
Q2 		$232K Buy
+2,668
New +$213K 0.05% 268
2020
Q1 		– Sell
-2,730
Closed -$253K – 327
2019
Q4 		$253K Buy
2,730
+31
+1% +$2.73K 0.05% 296
2019
Q3 		$244K Buy
+2,699
New +$308K 0.05% 274

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Calton & Associates's EXAS Position: Q3 2023 in Review

Calton & Associates sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,588 shares — an estimated $243K sold.

Calton & Associates first reported a position in EXAS in Q3 2019 and held it in 8 quarters. The position peaked at $263K in Q3 2020. 625 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Calton & Associates reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Calton & Associates sold 2,588 Exact Sciences shares in Q3 2023, an estimated $243K.
  • Calton & Associates first reported a position in Exact Sciences in Q3 2019 and held it in 8 quarters.
  • Calton & Associates's Exact Sciences position peaked at $263K in Q3 2020.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Calton & Associates's 13F filing for Q3 2023, filed 1 Nov 2023.